Startup India Government of India
Tabilac Pharmaceuticals Private Limited - pharma in Sonipat, Haryana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹4.06 Cr
▲ 1213% YoY
Net profit · FY 2024
₹6.69 Lakh
Net margin 1.6%
EBITDA · FY 2024
₹13.93 Lakh
EBITDA margin 3.4%
Authorised capital
₹2.3 Cr
Registered with MCA
Paid-up capital
₹2.3 Cr
Issued & subscribed
Open charges
₹3.26 Cr
Secured borrowings
Company age
5 yrs
Est. 2021
Directors on board
3
As per MCA filings
About Tabilac Pharmaceuticals Private Limited
Data last updated:
Tabilac Pharmaceuticals Private Limited is a private limited company based in Sonipat, Haryana, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 October 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24231HR2021PTC098804. Its GSTIN is 06AAICT9648J1ZO (Haryana).
The company has an authorised share capital of ₹2.3 Cr and a paid-up capital of ₹2.3 Cr. It is led by directors including Jitender Saroha and Sagar Saroha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 1396 Hsiidc Rai Industrial Estate Rai, Sonipat, Haryana, India – 131029.
As per the financials filed for FY 2024, the company reported a revenue of ₹4.06 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹6.69 Lakh (net margin 1.6%) and EBITDA of ₹13.93 Lakh (EBITDA margin 3.4%).
As per MCA filings, the company has open charges of ₹3.26 Cr on record. Court records list 1 case involving the company, including 1 filed against it.
Tabilac Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-18-0013454). For more details, the company can be reached via its website tabilac.in.
Company details
CIN U24231HR2021PTC098804
Registration Number 098804
Incorporation Date 27 October 2021
ROC Haryana
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-HR-18-0013454
Recognitions & Rankings of Tabilac Pharmaceuticals
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-HR-18-0013454
Contact details
Tabilac Pharmaceuticals Private Limited's registered office is in Sonipat, Haryana. Its website is tabilac.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No. 1396 Hsiidc Rai Industrial Estate Rai, Sonipat, Haryana, India – 131029
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Tabilac Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Tabilac Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Tabilac Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Tabilac Pharmaceuticals Private Limited, buy the company report.
Financials of Tabilac Pharmaceuticals Private Limited
FY 2025 filings availableTabilac Pharmaceuticals Private Limited reported revenue of ₹4.06 Cr (up 1213% YoY) for FY 2024.
Revenue · FY 2024
₹4.06 Cr ▲ 1213%
Net profit · FY 2024
₹6.69 Lakh margin 1.6%
EBITDA · FY 2024
₹13.93 Lakh margin 3.4%
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹13.93 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹6.69 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 3.4% | ||
| Net Profit Margin | 1.6% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Tabilac Pharmaceuticals Private Limited, buy the company report.
Board of directors of Tabilac Pharmaceuticals Private Limited
Tabilac Pharmaceuticals has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jitender Saroha | Director | 27 Oct 2021 | 5 Years 0 Months | Current |
| Sagar Saroha | Director | 27 Oct 2021 | 5 Years 0 Months | Current |
| Sahil Saroha | Director | 27 Oct 2021 | 5 Years 0 Months | Current |
Peer comparison
Tabilac Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| MSR Pharmaceuticals Private Limited | ₹4.11 Cr (FY 2025) | -10.0% | Patna, Bihar, India | |||
| Orcas Pharmaceuticals Private Limited | ₹4.08 Cr (FY 2024) | 19.0% | Pennagaram, Tamil Nadu, India | |||
| Tabilac Pharmaceuticals Private Limitedthis company | ₹4.06 Cr (FY 2024) | ₹6.69 Lakh | 1.6% | 1213.0% | Sonipat, Haryana, India | |
| Biomodex Pharmaceuticals Private Limited | ₹4.02 Cr (FY 2025) | 39.0% | New Delhi, Delhi, India | |||
| Chiron Pharmaceuticals Private Limited | ₹4 Cr (FY 2024) | 11.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Tabilac Pharmaceuticals Private Limited, buy the company report.
Auditor
Tabilac Pharmaceuticals Private Limited is audited by B K AGARWAL & CO. for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B K AGARWAL & CO. | FY 2022 | 0014755S |
Shareholding
The shareholding of Tabilac Pharmaceuticals Private Limited is on record for FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Tabilac Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹3.26 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 10 Dec 2025 | 101210465 | State Bank of India | ₹3.2 Cr | Open | |
| 22 Aug 2022 | 100667847 | Hdfc Bank Limited | ₹5.56 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
Tabilac Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Total cases
1
Filed against the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, North West, Delhi | Cheque dishonour complaint | Filed against the company by an individual | Disposed |
To see the full case history of Tabilac Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Tabilac Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Tabilac Pharmaceuticals Private Limited has 1 active EPFO establishment as of Mar 31, 2024.
Active EPFO establishments
1
GST
Tabilac Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAICT9648J1ZO | Haryana | Active | 17 Nov 2021 |
To see the full GST registrations and return filing status of Tabilac Pharmaceuticals Private Limited, buy the company report.
Recent activity
Tabilac Pharmaceuticals Private Limited has 3 board changes on record since 2021: 3 appointments. The latest: Jitender Saroha was appointed as Director on 27 Oct 2021.
Charges
A charge with State Bank Of India amounted to Rs. 3.20 Cr with Charge ID 101210465 was registered on 10 Dec 2025.
AGM
Tabilac Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Tabilac Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Haryana.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.06 Cr with Charge ID 100667847 was registered on 22 Aug 2022.
Appointed
Jitender Saroha was appointed as Director.
Appointed
Sagar Saroha was appointed as Director.
Appointed
Sahil Saroha was appointed as Director.
Incorporation
27 Oct 2021
Tabilac Pharmaceuticals Private Limited was registered on 27 Oct 2021 with Roc Haryana & aged 5 years 1 day as per MCA records.
Frequently asked questions
Tabilac Pharmaceuticals is an active private limited company based in Sonipat, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 October 2021 (5+ years old) and is registered under CIN U24231HR2021PTC098804.
Tabilac Pharmaceuticals has 3 current directors:
- Jitender Saroha - Director
- Sagar Saroha - Director
- Sahil Saroha - Director
The latest financial statements of Tabilac Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Tabilac Pharmaceuticals is 06AAICT9648J1ZO, registered in Haryana.
The CIN (Corporate Identification Number) of Tabilac Pharmaceuticals is U24231HR2021PTC098804. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Tabilac Pharmaceuticals has 1 court case on record: 1 filed against it.
Tabilac Pharmaceuticals was incorporated on 27 October 2021, making it 5+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Tabilac Pharmaceuticals by revenue are MSR Pharmaceuticals Private Limited, Orcas Pharmaceuticals Private Limited, Biomodex Pharmaceuticals Private Limited, Chiron Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Jitender Saroha was appointed as Director on 27 Oct 2021. Sagar Saroha was appointed as Director on 27 Oct 2021. Sahil Saroha was appointed as Director on 27 Oct 2021.
Yes, Tabilac Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Tabilac Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-18-0013454).